I agree that this site is using cookies. You can find further informations here.
X
del Río-Garma, Julio
22  results:
Search for persons X
?
1

Recommendations for the diagnosis and treatment of patients..:

Mingot Castellano, María Eva ; Pascual Izquierdo, Cristina ; González, Ataulfo...
Medicina Clínica (English Edition).  158 (2022)  12 - p. 630.e1-630.e14 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Mortality in acquired thrombotic thrombocytopenic purpura i..:

del Río-Garma, Julio ; Bobillo, Sabela ; de la Rubia, Javier...
Annals of Hematology.  101 (2021)  1 - p. 59-67 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Guía diagnóstica y terapéutica de las microangiopatías trom..:

Contreras, Enric ; de la Rubia, Javier ; del Río-Garma, Julio...
Medicina Clínica.  144 (2015)  7 - p. 331.e1-331.e13 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Diagnostic and therapeutic guidelines of thrombotic microan..:

Contreras, Enric ; de la Rubia, Javier ; del Río-Garma, Julio...
Medicina Clínica (English Edition).  144 (2015)  7 - p. 331.e1-331.e13 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Newly diagnosed versus relapsed idiopathic thrombotic throm..:

Alvarez-Larrán, Alberto ; del Río-Garma, Julio ; Pujol, Misericòrdia...
Annals of Hematology.  88 (2009)  10 - p. 973-978 , 2009
Link: https://doi.org/10.1007/..
 
?
6

Spanish registry of thrombotic thrombocytopenic purpura (RE..:

Mingot-Castellano, María Eva ; Izquierdo, Cristina Pascual ; del Rio Garma, Julio
Transfusion and Apheresis Science.  62 (2023)  3 - p. 103725 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of rituximab in adult patients with idi..:

Rubia, Javier de la ; Moscardó, Federico ; Gómez, María J...
Transfusion and Apheresis Science.  43 (2010)  3 - p. 299-303 , 2010
Link: https://doi.org/10.1016/..
 
?
8

Real-world effectiveness of caplacizumab vs the standard of..:

Izquierdo, Cristina Pascual ; Mingot-Castellano, María Eva ; Fuentes, Ana E. Kerguelen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792393/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual, Cristina ; Mingot-Castellano, María Eva ; Kerguelen Fuentes, Ana E...
Blood advances.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
10

P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER ..:

Seguí, Inés Gómez ; Aracil, Eva Frances ; Eva, Mingot-Castellano Maria...
HemaSphere.  7 (2023)  S3 - p. e929835e , 2023
Link: https://doi.org/10.1097/..
 
?
11

P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER ..:

Inés Gómez Seguí ; Eva Frances Aracil ; Mingot-Castellano Maria Eva...
http://journals.lww.com/10.1097/01.HS9.0000973296.92983.5e.  , 2023
Link: https://doi.org/10.1097/..
 
?
12

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual Izquierdo, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana E...
2473-9529.  , 2023
Link: http://hdl.handle.net/10..
 
?
13

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual-Izquierdo, Cristina ; Mingot-Castellano, María Eva ; Fuentes, Ana...
Publisher's version.  , 2022
Link: http://hdl.handle.net/10..
 
?
14

Guía diagnóstica y terapéutica de las microangiopatías trom..:

Del Río Garma, Julio
0025-7753.  , 2015
Link: https://hdl.handle.net/2..
 
?
15

Púrpura trombótica trombocitopénica:

Del Río Garma, Julio
0025-7753.  , 2011
Link: https://hdl.handle.net/2..
 
1-15